XML 38 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Stock-Based Compensation Expense by Award Type

The Company’s stock-based compensation expense by award type was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Stock options

 

$

9,015

 

 

$

7,779

 

Restricted stock units

 

 

679

 

 

 

 

Employee stock purchase plan

 

 

226

 

 

 

238

 

 

 

$

9,920

 

 

$

8,017

 

Stock-Based Compensation Expense

The Company recorded aggregate stock-based compensation expense in the consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

5,031

 

 

$

4,047

 

General and administrative

 

 

4,889

 

 

 

3,970

 

 

 

$

9,920

 

 

$

8,017

 

Summary of Unvested RSUs Activity Under 2015 Plan

The following table summarizes restricted stock unit activity under the 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Unvested balance at December 31, 2020

 

 

 

 

$

 

Granted

 

 

257

 

 

$

44.92

 

Vested

 

 

 

 

$

 

Forfeited

 

 

(3

)

 

$

44.97

 

Unvested balance at March 31, 2021

 

 

254

 

 

$

44.92

 

2014 and 2015 Equity Incentive Plan [Member]  
Summary of Stock Option Activity

The following table summarizes stock option activity under the 2014 Plan and 2015 Plan (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

average

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

 

Exercise

 

 

Life

 

 

Intrinsic

 

 

 

Shares

 

 

Price

 

 

(Years)

 

 

Value (a)

 

Outstanding at December 31, 2020

 

 

6,361

 

 

$

31.21

 

 

 

7.2

 

 

$

101,356

 

Granted

 

 

1,170

 

 

$

44.92

 

 

 

 

 

 

 

 

 

Exercised

 

 

(105

)

 

$

12.30

 

 

 

 

 

 

 

 

 

Cancelled or forfeited

 

 

(80

)

 

$

45.48

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2021

 

 

7,346

 

 

$

33.51

 

 

 

7.4

 

 

$

51,356

 

Exercisable at March 31, 2021

 

 

4,126

 

 

$

26.47

 

 

 

6.2

 

 

$

50,065

 

Vested and expected to vest at March 31, 2021

 

 

7,346

 

 

$

33.51

 

 

 

7.4

 

 

$

51,356

 

 

(a)

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of the common stock for the options that were in the money at the dates reported.